Make your quotes and reservations by email [email protected], you can also communicate with one of our sales executives at the telephones detailed below, we will be happy to assist you
This finding is particularly noteworthy given that some trials extended to 24 weeks of continuous exposure and included participants with obesity-related comorbidities who might be expected to have higher baseline health risks
AOD 9604 demonstrated a strong safety profile in more than 900 participants in Phase II human trials, with no serious adverse events
Our medical team prescribes, dispenses, and monitors every dose of AOD 9604 on site
modified insulin-like growth factor-1, TB-500, hematide/peginesatide, growth hormone releasing peptides, AOD-9604, etc.) and non-peptidic (selective androgen receptor modulators, hypoxia-inducible factor stabilizers, siRNA, S-107 and ARM036/aladorian, etc.) as well as inorganic (cobalt) nature are considered and discussed in terms of specific requirements originating from physicochemical properties, concentration levels, metabolism, and their amenability for chromatographic-mass spectrometric or alternative detection methods
Short-term storage at room temperature is acceptable for a few weeks without significant quality loss